Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins - PubMed (original) (raw)
Review
Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
J D Harper et al. Annu Rev Biochem. 1997.
Abstract
Ordered protein aggregation in the brain is a hallmark of Alzheimer's disease and scrapie. The disease-specific amyloid fibrils comprise primarily a single protein, amyloid beta, in Alzheimer's disease, and the prion protein in scrapie. These proteins can be induced to form aggregates in vitro that are indistinguishable from brain-derived fibrils. Consequently, much effort has been invested in the development of in vitro model systems to study the details of the aggregation processes and the effects of endogenous molecules that have been implicated in disease. Selected studies of this type are reviewed herein. A simple mechanistic model has emerged for both processes that involves a nucleation-dependent polymerization. This mechanism dictates that aggregation is dependent on protein concentration and time. Furthermore, amyloid formation can be seeded by a preformed fibril. The physiological consequences of this mechanism are discussed.
Similar articles
- Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N, Zhou M, Giralt E, Robinson CV, Dobson CM. Carulla N, et al. Acc Chem Res. 2010 Aug 17;43(8):1072-9. doi: 10.1021/ar9002784. Acc Chem Res. 2010. PMID: 20557067 - Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC. Meredith SC. Ann N Y Acad Sci. 2005 Dec;1066:181-221. doi: 10.1196/annals.1363.030. Ann N Y Acad Sci. 2005. PMID: 16533927 Review. - In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
Benseny-Cases N, Klementieva O, Cladera J. Benseny-Cases N, et al. Subcell Biochem. 2012;65:53-74. doi: 10.1007/978-94-007-5416-4_3. Subcell Biochem. 2012. PMID: 23224999 Review. - Amyloid beta protein and the basis for Alzheimer's disease.
Glenner GG. Glenner GG. Prog Clin Biol Res. 1989;317:857-68. Prog Clin Biol Res. 1989. PMID: 2690126 Review.
Cited by
- Charge effects on the fibril-forming peptide KTVIIE: a two-dimensional replica exchange simulation study.
Jeon J, Shell MS. Jeon J, et al. Biophys J. 2012 Apr 18;102(8):1952-60. doi: 10.1016/j.bpj.2012.03.019. Biophys J. 2012. PMID: 22768952 Free PMC article. - Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects.
Marek PJ, Patsalo V, Green DF, Raleigh DP. Marek PJ, et al. Biochemistry. 2012 Oct 30;51(43):8478-90. doi: 10.1021/bi300574r. Epub 2012 Oct 16. Biochemistry. 2012. PMID: 23016872 Free PMC article. - Mechanistic and environmental control of the prevalence and lifetime of amyloid oligomers.
Morris RJ, Eden K, Yarwood R, Jourdain L, Allen RJ, Macphee CE. Morris RJ, et al. Nat Commun. 2013;4:1891. doi: 10.1038/ncomms2909. Nat Commun. 2013. PMID: 23695685 Free PMC article. - Transmissibility of systemic amyloidosis by a prion-like mechanism.
Lundmark K, Westermark GT, Nyström S, Murphy CL, Solomon A, Westermark P. Lundmark K, et al. Proc Natl Acad Sci U S A. 2002 May 14;99(10):6979-84. doi: 10.1073/pnas.092205999. Proc Natl Acad Sci U S A. 2002. PMID: 12011456 Free PMC article. - Thermodynamic analysis of the aggregation propensity of oxidized Alzheimer's beta-amyloid variants.
Hortschansky P, Christopeit T, Schroeckh V, Fändrich M. Hortschansky P, et al. Protein Sci. 2005 Nov;14(11):2915-8. doi: 10.1110/ps.051585905. Epub 2005 Sep 30. Protein Sci. 2005. PMID: 16199659 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical